The impact of mass drug administration on Schistosoma haematobium infection: what is required to achieve morbidity control and elimination?

The impact of mass drug administration on Schistosoma haematobium infection: what is required to achieve morbidity control and elimination?

Abstract Background Schistosomiasis remains an endemic parasitic disease causing much morbidity and, in some cases, mortality. The World Health Organization (WHO) has outlined strategies and goals to combat the burden of disease caused by schistosomiasis. The first goal is morbidity control, which i...

Full description

Bibliographic Details
Main Authors: Klodeta Kura, Robert J. Hardwick, James E. Truscott, Jaspreet Toor, T. Deirdre Hollingsworth, Roy M. Anderson
Format: Article
Language:English
Published: BMC 2020-11-01
Series:Parasites & Vectors
Subjects:
Schistosomiasis
Modelling
Mass drug administration
School-based treatment
Community-wide treatment
Morbidity control
Online Access:http://link.springer.com/article/10.1186/s13071-020-04409-3

Internet

http://link.springer.com/article/10.1186/s13071-020-04409-3

Similar Items